Reaction Details |
| Report a problem with these data |
Target | Cholecystokinin |
---|
Ligand | BDBM50019274 |
---|
Substrate/Competitor | n/a |
---|
Ki | >10000±n/a nM |
---|
Comments | PDSP_17 |
---|
Citation | Evans, BE; Bock, MG; Rittle, KE; DiPardo, RM; Whitter, WL; Veber, DF; Anderson, PS; Freidinger, RM Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin. Proc Natl Acad Sci U S A83:4918-22 (1986) [PubMed] Article |
---|
More Info.: | Get all data from this article |
---|
|
Cholecystokinin |
---|
Name: | Cholecystokinin |
Synonyms: | CCKN_RAT | Cck |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 12844.29 |
Organism: | RAT |
Description: | Cholecystokinin 0 RAT::P01355 |
Residue: | 115 |
Sequence: | MKCGVCLCVVMAVLAAGALAQPVVPVEAVDPMEQRAEEAPRRQLRAVLRPDSEPRARLGA
LLARYIQQVRKAPSGRMSVLKNLQGLDPSHRISDRDYMGWMDFGRRSAEDYEYPS
|
|
|
BDBM50019274 |
---|
n/a |
---|
Name | BDBM50019274 |
Synonyms: | CCK antagonist synthetic 16 | CHEMBL72057 | N-[5-(2-Fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-acetamide |
Type | Small organic molecule |
Emp. Form. | C17H14FN3O2 |
Mol. Mass. | 311.3104 |
SMILES | CC(=O)NC1N=C(c2ccccc2F)c2ccccc2NC1=O |t:5| |
Structure |
|